Use of hormonal therapy for undescended testis: Results of a worldwide questionnaire

Lammers R. J. M., 't Hoen L. A., O'Kelly F., Selvi I., Madarriaga Y. Q., BAYDİLLİ N., ...Daha Fazla

ACTAS UROLOGICAS ESPANOLAS, cilt.49, sa.10, 2025 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 49 Sayı: 10
  • Basım Tarihi: 2025
  • Doi Numarası: 10.1016/j.acuro.2025.501820
  • Dergi Adı: ACTAS UROLOGICAS ESPANOLAS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, MEDLINE, DIALNET
  • İstanbul Üniversitesi Adresli: Hayır

Özet

The objective of this study was to provide an overview of current practices on hormonal therapy (HT) in children with undescended testes (UDT). An online questionnaire about HT, referral patterns, and orchidopexy was spread via several (social media) networks involved in pediatric urology. A total of 283 individuals responded, with 54 countries sampled. The majority (84%) did not prescribe HT for UDT, predominantly due to a paucity of scientific evidence (76%). Among those who use HT, main reason was bilateral UDT (62%). There was no clear preference in administration type (50% intramuscular injection, 50% nasal spray). GnRH was slightly more favoured over HCG (50% vs. 32%). No standardized schedule was used. Most respondents (67%) felt all forms of UDT should be treated by either a pediatric urologist or-surgeon. Eighty-seven percent follow the current guidelines and perform orchidopexy between 6-18 months of age. (c) 2025 The Authors. Published by Elsevier Espana, S.L.U. on behalf of AEU. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).